Next Article in Journal
Efficacy and Effect on Liver Functional Reserve of Atezolizumab and Bevacizumab for Unresectable Hepatocellular Carcinoma in Patients Who Do Not Meet Eligibility Criteria of IMbrave150
Next Article in Special Issue
Proton Beam Therapy for Esophageal Cancer
Previous Article in Journal
Relationship of FDG PET/CT Textural Features with the Tumor Microenvironment and Recurrence Risks in Patients with Advanced Gastric Cancers
Previous Article in Special Issue
Combined Systemic Drug Treatment with Proton Therapy: Investigations on Patient-Derived Organoids
 
 
Systematic Review

Article Versions Notes

Cancers 2022, 14(16), 3937; https://doi.org/10.3390/cancers14163937
Action Date Notes Link
article pdf uploaded. 15 August 2022 16:50 CEST Version of Record https://www.mdpi.com/2072-6694/14/16/3937/pdf-vor
article supplementary file uploaded. 15 August 2022 16:50 CEST - https://www.mdpi.com/2072-6694/14/16/3937#supplementary
article xml file uploaded 16 August 2022 11:35 CEST Original file -
article xml uploaded. 16 August 2022 11:35 CEST Update https://www.mdpi.com/2072-6694/14/16/3937/xml
article pdf uploaded. 16 August 2022 11:35 CEST Updated version of record https://www.mdpi.com/2072-6694/14/16/3937/pdf
article html file updated 16 August 2022 11:37 CEST Original file -
article html file updated 17 August 2022 10:13 CEST Update https://www.mdpi.com/2072-6694/14/16/3937/html
Back to TopTop